2/22/12 Journal of Clinical Microbiology Publishes Study Demonstrating Accuracy and Specificity of Great Basin Corporation’s Staph ID/R Molecular Diagnostic Test

11/14/2011 Great Basin Corporation Submits 510(K) Application to FDA for C. Difficile Molecular Diagnostic Test

6/28/2011 Great Basin Corporation Initiates First Clinical Trial For C. difficile Molecular Diagnostic Test

2/14/2011 Great Basin Hires Key Executive to Prepare for Commercial Launch

6/17/2009 Great Basin Raises 3.6M in Bridge Funding

11/10/2008 Great Basin Names Laurence Rea VP Operations

10/7/2008 Great Basin Closes Equity Funding

5/21/2008 Great Basin Names Jeffery Selander as Chief Financial Officer

5/21/2007 Great Basin Names Associate Director Of Research And Development

1/29/2007 Great Basin Expands Leadership Team

1/29/2007 Great Basin Opens New Strategic Research Laboratory in Colorado

7/3/2006 Great Basin Announces Patent Filing for Innovative Molecular Diagnostics Technology

12/1/2005 Great Basin Files for Additional Patents

7/28/2005 Great Basin Licenses Technology from Yale

1/20/2005 Great Basin Closes Round of Funding

12/27/2004 Great Basin Announces New CEO